BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $509,833 | -20.5% | 10,152 | 0.0% | 0.01% | -18.2% |
| Q2 2023 | $641,606 | +40.5% | 10,152 | 0.0% | 0.01% | +37.5% |
| Q1 2023 | $456,738 | +2.7% | 10,152 | 0.0% | 0.01% | -11.1% |
| Q4 2022 | $444,759 | -33.5% | 10,152 | 0.0% | 0.01% | -35.7% |
| Q3 2022 | $669,000 | +30.4% | 10,152 | 0.0% | 0.01% | +27.3% |
| Q2 2022 | $513,000 | -21.0% | 10,152 | 0.0% | 0.01% | -8.3% |
| Q1 2022 | $649,000 | -40.3% | 10,152 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $1,087,000 | +4.1% | 10,152 | 0.0% | 0.02% | -5.3% |
| Q3 2021 | $1,044,000 | +16.9% | 10,152 | 0.0% | 0.02% | +11.8% |
| Q2 2021 | $893,000 | -9.5% | 10,152 | 0.0% | 0.02% | -15.0% |
| Q1 2021 | $987,000 | -13.3% | 10,152 | 0.0% | 0.02% | -16.7% |
| Q4 2020 | $1,139,000 | +10.2% | 10,152 | -9.0% | 0.02% | 0.0% |
| Q3 2020 | $1,034,000 | +18.9% | 11,152 | 0.0% | 0.02% | +9.1% |
| Q2 2020 | $870,000 | +33.4% | 11,152 | 0.0% | 0.02% | +15.8% |
| Q1 2020 | $652,000 | -27.0% | 11,152 | 0.0% | 0.02% | -9.5% |
| Q4 2019 | $893,000 | +9.0% | 11,152 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $819,000 | -22.1% | 11,152 | 0.0% | 0.02% | -25.0% |
| Q2 2019 | $1,052,000 | +64.4% | 11,152 | +39.4% | 0.03% | +64.7% |
| Q1 2019 | $640,000 | +48.5% | 8,000 | 0.0% | 0.02% | +30.8% |
| Q4 2018 | $431,000 | -30.9% | 8,000 | 0.0% | 0.01% | -27.8% |
| Q3 2018 | $624,000 | +22.8% | 8,000 | 0.0% | 0.02% | +20.0% |
| Q2 2018 | $508,000 | -30.8% | 8,000 | 0.0% | 0.02% | -34.8% |
| Q1 2018 | $734,000 | +21.7% | 8,000 | 0.0% | 0.02% | +27.8% |
| Q4 2017 | $603,000 | -17.3% | 8,000 | -23.6% | 0.02% | -18.2% |
| Q3 2017 | $729,000 | +15.3% | 10,468 | -16.0% | 0.02% | +15.8% |
| Q2 2017 | $632,000 | +54.1% | 12,468 | +21.5% | 0.02% | +46.2% |
| Q1 2017 | $410,000 | +86.4% | 10,265 | +30.9% | 0.01% | +85.7% |
| Q4 2016 | $220,000 | -5.6% | 7,843 | 0.0% | 0.01% | -12.5% |
| Q3 2016 | $233,000 | – | 7,843 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |